Patil Chirag G, Prevedello Daniel M, Lad Shivanand P, Vance Mary Lee, Thorner Michael O, Katznelson Laurence, Laws Edward R
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA.
J Clin Endocrinol Metab. 2008 Feb;93(2):358-62. doi: 10.1210/jc.2007-2013. Epub 2007 Dec 4.
Few studies have systematically analyzed the long-term recurrence rates of Cushing's disease after initial successful transsphenoidal surgery.
This was a retrospective review of patients treated at the University of Virginia Medical Center.
A total of 215 subjects with Cushing's disease who underwent initial transsphenoidal surgery for resection of a presumed pituitary microadenoma from 1992-2006 were included.
Remission and recurrence rates of Cushing's disease were examined. Recurrence was defined as an elevated 24-h urine free cortisol with clinical symptoms consistent with Cushing's disease.
Of the 215 patients who underwent transsphenoidal surgery for Cushing's disease, surgical remission was achieved in 184 (85.6%). The mean length of follow-up was 45 months. Actuarial recurrence rates of Cushing's disease after initially successful transsphenoidal surgery at 1, 2, 3, and 5 yr were 0.5, 6.7, 10.8, and 25.5%, respectively. Among the 184 patients who achieved remission, 32 (17.4%) patients followed for more than 6 months ultimately had a recurrence of Cushing's disease. The median time to recurrence was 39 months. Immediate postoperative hypocortisolemia (serum cortisol < or = 2 microg/dl within 72-h surgery) was achieved in 97 (45.1%) patients. Patients who had postoperative serum cortisol of more than 2 microg/dl were 2.5 times more likely to have a recurrence than patients who had serum cortisol less than or equal to 2 microg/dl (odds ratio = 2.5; 95% confidence interval 1.12-5.52; P = 0.022).
A quarter of the patients with Cushing's disease who achieve surgical remission after transsphenoidal surgery, recur with long-term follow-up. This finding emphasizes the need for continued biochemical and clinical follow-up to ensure remission after surgery.
很少有研究系统分析首次经蝶窦手术成功后库欣病的长期复发率。
这是对弗吉尼亚大学医学中心治疗的患者进行的回顾性研究。
纳入了1992年至2006年间共215例因疑似垂体微腺瘤接受首次经蝶窦手术切除的库欣病患者。
检查库欣病的缓解率和复发率。复发定义为24小时尿游离皮质醇升高且伴有与库欣病一致的临床症状。
在215例行经蝶窦手术治疗库欣病的患者中,184例(85.6%)实现了手术缓解。平均随访时间为45个月。首次经蝶窦手术成功后1年、2年、3年和5年库欣病的精算复发率分别为0.5%、6.7%、10.8%和25.5%。在184例实现缓解的患者中,32例(17.4%)随访超过6个月最终出现库欣病复发。复发的中位时间为39个月。97例(45.1%)患者术后立即出现低皮质醇血症(术后72小时内血清皮质醇≤2μg/dl)。术后血清皮质醇>2μg/dl的患者复发的可能性是血清皮质醇≤2μg/dl患者的2.5倍(优势比=2.5;95%置信区间1.12 - 5.52;P = 0.022)。
经蝶窦手术后实现手术缓解的库欣病患者中有四分之一在长期随访中复发。这一发现强调了持续进行生化和临床随访以确保术后缓解的必要性。